Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
Open Access
- 22 October 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the most overlooked cancers despite its dismal median survival time of 6 months. The biggest challenges in improving patient survival are late diagnosis due to lack of diagnostic markers, and limited treatment options due to almost complete therapy resistance. The past decades of research identified the dense stroma and the complex interplay/crosstalk between the cancer- and the different stromal cells as the main culprits for the slow progress in improving patient outcome. For better ex vivo simulation of this complex tumor microenvironment the models used in PDAC research likewise need to become more diverse. Depending on the focus of the investigation, several in vitro and in vivo models for PDAC have been established in the past years. Particularly, 3D cell culture such as spheroids and organoids have become more frequently used. This review aims to examine current PDAC in vitro models, their inherent limitations, and their successful implementations in research.Keywords
This publication has 81 references indexed in Scilit:
- 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testingBMC Cancer, 2013
- Xenome—a tool for classifying reads from xenograft samplesBioinformatics, 2012
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular MatricesMolecular & Cellular Proteomics, 2012
- Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic CancerCancer Research, 2011
- Spheroid-based drug screen: considerations and practical approachNature Protocols, 2009
- Role of bone marrow-derived cells in experimental chronic pancreatitisGut, 2008
- Myofibroblast contraction activates latent TGF-β1 from the extracellular matrixThe Journal of cell biology, 2007
- Force-Induced Unfolding of Fibronectin in the Extracellular Matrix of Living CellsPLoS Biology, 2007
- Pancreatic cancer microenvironmentInternational Journal of Cancer, 2007
- Activation of Pancreatic Stellate Cells in Human and Experimental Pancreatic FibrosisThe American Journal of Pathology, 1999